• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. Acetyl protected thiol methacrylic polymers as effective ligands to keep quantum dots in luminescent standby mode?
  Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442
• 3. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 4. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Recent Advances in the Study of 6-Methylbenzothiazole (CAS: 2942-15-6) in Chemical Biology and Pharmaceutical Research

6-Methylbenzothiazole (CAS: 2942-15-6) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by a benzothiazole core with a methyl substituent at the 6-position, has been explored for its potential in drug discovery, fluorescence imaging, and as a building block for more complex molecules. Recent studies have highlighted its role in modulating biological pathways, particularly in the context of neurodegenerative diseases and cancer therapeutics.

A 2023 study published in the Journal of Medicinal Chemistry investigated the neuroprotective effects of 6-methylbenzothiazole derivatives in models of Alzheimer's disease. The researchers synthesized a series of analogs and evaluated their ability to inhibit amyloid-beta aggregation, a hallmark of the disease. The results demonstrated that certain derivatives exhibited potent inhibitory activity, with IC50 values in the low micromolar range. Molecular docking studies further revealed that these compounds interact with key residues in the amyloid-beta peptide, providing insights into their mechanism of action.

In the field of oncology, 6-methylbenzothiazole has been explored as a scaffold for developing kinase inhibitors. A recent preprint on bioRxiv described the design and synthesis of novel 6-methylbenzothiazole-based compounds targeting the epidermal growth factor receptor (EGFR). The lead compound in this series showed promising activity against EGFR-mutant non-small cell lung cancer (NSCLC) cell lines, with selective inhibition of proliferation and induction of apoptosis. These findings suggest that 6-methylbenzothiazole derivatives could serve as a starting point for developing next-generation targeted therapies.

Beyond its therapeutic potential, 6-methylbenzothiazole has also found applications in fluorescence-based sensing. A 2024 study in Analytical Chemistry reported the development of a 6-methylbenzothiazole-derived fluorescent probe for detecting reactive oxygen species (ROS) in live cells. The probe exhibited high selectivity for hydroxyl radicals and demonstrated excellent photostability, making it a valuable tool for studying oxidative stress in biological systems. This work underscores the compound's utility as a versatile platform for designing molecular probes.

From a synthetic chemistry perspective, recent advances have focused on improving the efficiency of 6-methylbenzothiazole production. A green chemistry approach published in Organic Process Research & Development described a catalytic method for the synthesis of 6-methylbenzothiazole using environmentally benign reagents. This method achieved high yields (85-90%) with minimal waste generation, addressing some of the sustainability challenges associated with traditional synthetic routes.

In conclusion, the growing body of research on 6-methylbenzothiazole (CAS: 2942-15-6) highlights its multifaceted role in chemical biology and pharmaceutical sciences. Its applications span from drug discovery to molecular imaging, with recent studies providing deeper insights into its mechanisms of action and potential therapeutic benefits. As synthetic methodologies continue to evolve and biological investigations expand, 6-methylbenzothiazole is poised to remain a compound of significant interest in the coming years.

• 95-16-9(Benzothiazole)
• 3048-47-3(Benzothiazole,7-methyl-)
• 3119-45-7(Thiazolo[5,4-f]quinoline,9-methyl-)
• 19989-66-3(Benzo[d]thiazol-6-ylmethanol)
• 499770-92-2(6-(Aminomethyl)benzothiazole)
• 346465-91-6(Benzothiazole,4,5-dimethyl-)
• 118220-72-7(Benzothiazole, 6-ethyl-)
• 637775-69-0(Benzothiazole,5,6-dimethyl-)
• 3048-48-4(4-Methylbenzothiazole)
• 2941-71-1(2,6-Dimethyl-1,3-benzothiazole)